Analysts
Most recent initiations
| Proteome Sciences | Clavis Pharma |
| TiGenix | Transgene |
| BioInvent | MediGene |
Recent QuickViews
Stratec Biomedical
Two growth scenarios
Pharmaceutical & Healthcare | published 17/05/2012
United Drug
Diversification pays off
Pharmaceutical & Healthcare | published 14/05/2012
Sucampo Pharmaceuticals
Awaiting Amitiza arbitration
Pharmaceutical & Healthcare | published 11/05/2012
AVEO Pharmaceuticals
Moment of truth
Pharmaceutical & Healthcare | published 08/05/2012
Would you like to be notified when new research is published? Access our research RSS feed
Healthcare sector team
Latest research
Algeta
50/50 vision
Update | Pharmaceutical & Healthcare | 14/05/2012Having exercised its option to co-promote Alpharadin, Algeta is set to enter the commercialisation process with Bayer on a 50/50 basis in the US. The project…
Oxford BioMedica
Solid LentiVector safety
Update | Pharmaceutical & Healthcare | 14/05/2012LentiVector’s favourable safety profile is further supported by clinical data presented at ARVO 2012 from the ocular programmes. To date no adverse…
4SC
Funding the next move
Update | Pharmaceutical & Healthcare | 14/05/20124SC remains focused on finding an ex-Japan partner for resminostat, the oral pan-HDAC inhibitor that could – funding permitting – enter a Phase…
Lombard Medical Technologies
Race against the clock
Update | Pharmaceutical & Healthcare | 11/05/2012The FDA’s requirement for additional analyses of the existing Aorfix dataset in the PMA process means that the clock on the 180-day review will be…
Phylogica
Growing the IP estate
Update | Pharmaceutical & Healthcare | 11/05/2012The grant of two new patents broadens Phylogica’s core IP portfolio and strengthens its potential to exploit its Phylomer peptide drug discovery…
Research methodology
Edison has significant expertise in analysing companies involved in the biotech, med-tech and diagnostic sub-sectors of the healthcare industry. We have a particular strength in biotech, where our approach combines rigorous financial analysis with detailed scientific appraisal of the merits of individual development programmes and the risks (scientific, regulatory and market) associated with them. We put particular attention on competitive dynamics within therapeutic areas and focus on evaluating the results of clinical trials. Sales projections are usually derived from epidemiologically-based models. We generally value companies on the basis of a risk-adjusted net present value of the cash flows that may be available under (real and hypothetical) licensing deals. As a result, we closely follow industry trends regarding biotech-pharma licensing deals.
Sector commentary
Sector reports
Sectors covered
Pharmaceutical & Healthcare Show companies
- 4SC
- Aastrom Biosciences
- AB Science
- Abcam
- Ablynx
- Achillion
- Actelion
- Active Biotech
- Addex Therapeutics
- Advanced Medical Solutions
- Agennix AG
- Alexza Pharmaceuticals
- Algeta
- Allergy Therapeutics
- Alliance Pharma
- Alnylam Pharmaceuticals
- AmpliPhi Biosciences
- Animalcare Group
- Anthera Pharmaceuticals
- Antisoma
- Ardea Biosciences
- Arena Pharmaceuticals
- Ariad Pharmaceuticals
- Ark Therapeutics Group
- Array BioPharma
- Arrowhead Research
- Asterand
- Astex Pharmaceuticals
- AstraZeneca
- AVEO Pharmaceuticals
- AVI BioPharma
- Axis-Shield
- Basilea
- Bavarian Nordic
- BioCryst Pharmaceuticals
- BioInvent
- BioLineRx
- Bionomics
- Biota Holdings
- Biotie Therapies Corp
- Biotron
- BTG
- Celldex Therapeutics
- Cellectis
- Circadian Technologies
- Clavis Pharma
- Clinuvel
- Consort Medical
- Curis
- Dechra Pharmaceuticals
- Deltex Medical
- DiaSorin
- e-Therapeutics
- EKF Diagnostics
- Endocyte
- EpiCept Corporation
- Epigenomics
- Epistem Holdings
- Evolva
- Evotec
- Exelixis
- Fusion IP
- Futura Medical
- Galapagos
- Genfit
- Genmab
- GlaxoSmithKline
- GW Pharmaceuticals
- Hybrigenics
- Idenix
- Immunodiagnostic Systems Holdings
- ImmuPharma
- Infinity Pharmaceuticals
- Inhibitex
- Innate Pharma
- Ipsogen
- IS Pharma
- Keryx Biopharmaceuticals
- Lifeline Scientific
- Ligand Pharmaceuticals
- Lombard Medical Technologies
- MagForce
- Medcom Tech
- MediGene
- Medivir
- Merrion Pharmaceuticals
- Micromet
- MolMed
- MorphoSys
- Neovacs
- NeuroSearch
- NextGen Sciences
- NicOx
- NorDiag
- Omega Diagnostics Group
- OncoGenex Pharmaceuticals
- Oncolytics Biotech Inc
- Optos
- Orexigen
- Orexo
- Oxford BioMedica
- Paion
- Pharmacyclics
- Pharmaxis
- Pharming Group
- Photocure
- Phylogica
- Phytopharm
- ProMetic Life Sciences
- Proteome Sciences
- Proximagen Group
- QRxPharma
- Renovo
- Sangamo BioSciences
- Shire
- Sinclair Pharma
- SkyePharma
- Smith & Nephew
- Sosei Group Corporation
- Source Bioscience
- Stratec Biomedical
- Sucampo Pharmaceuticals
- Sunesis Pharmaceuticals
- Synta Pharmaceuticals
- ThromboGenics
- TiGenix
- TopoTarget
- Transgene
- United Drug
- Vectura
- Vernalis
- Vivus
- WaferGen Biosystems
- Wilex
- YM BioSciences
- Zealand Pharma
- Zeltia
- Ziopharm Oncology
